| Chetan Y Safi, MD | |
|
985 Berkshire Blvd Ste 101, Wyomissing, PA 19610-1268 | |
| (610) 374-5599 | |
| (610) 375-1262 |
| Full Name | Chetan Y Safi |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 985 Berkshire Blvd Ste 101, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164886396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD477869 (Pennsylvania) | Primary |
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275802811 PECOS PAC ID: 2264691070 Enrollment ID: O20120315000035 |
News Archive
Linde Gas North America and Air Products today announced they have formed Hydrochlor, a 50-50 joint venture to supply high purity anhydrous hydrochloric acid (HCl) to the electronics and other industries.
The University of Minnesota announced today that it will lead a $9.7 million grant over the next five years from the National Institutes for Health BRAIN Initiative to develop a new implantable device and surgical procedure with the goal of restoring more natural hearing to people who are deaf or severely hard-of-hearing.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.
› Verified 8 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
Linde Gas North America and Air Products today announced they have formed Hydrochlor, a 50-50 joint venture to supply high purity anhydrous hydrochloric acid (HCl) to the electronics and other industries.
The University of Minnesota announced today that it will lead a $9.7 million grant over the next five years from the National Institutes for Health BRAIN Initiative to develop a new implantable device and surgical procedure with the goal of restoring more natural hearing to people who are deaf or severely hard-of-hearing.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chetan Y Safi, MD 985 Berkshire Blvd Ste 101, Wyomissing, PA 19610-1268 Ph: (610) 374-5599 | Chetan Y Safi, MD 985 Berkshire Blvd Ste 101, Wyomissing, PA 19610-1268 Ph: (610) 374-5599 |
News Archive
Linde Gas North America and Air Products today announced they have formed Hydrochlor, a 50-50 joint venture to supply high purity anhydrous hydrochloric acid (HCl) to the electronics and other industries.
The University of Minnesota announced today that it will lead a $9.7 million grant over the next five years from the National Institutes for Health BRAIN Initiative to develop a new implantable device and surgical procedure with the goal of restoring more natural hearing to people who are deaf or severely hard-of-hearing.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.
› Verified 8 days ago
Dr. Joseph R Watson, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Granite Point Dr, Suite 300, Wyomissing, PA 19610 Phone: 610-376-3738 Fax: 610-376-4780 | |
Dr. Jeffrey S. Driben, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 985 Berkshire Blvd, Ste 101, Wyomissing, PA 19610 Phone: 610-374-5599 Fax: 610-288-8075 | |
Scott J. Cronin, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 985 Berkshire Blvd, Suite 101, Wyomissing, PA 19610 Phone: 610-374-5599 Fax: 610-375-1262 | |
Dr. Charles K. Lutz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 985 Berkshire Blvd, Ste 101, Wyomissing, PA 19610 Phone: 610-374-5599 Fax: 610-288-8075 | |
Dr. Gianfranco Toso, M.D., D.D.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Granite Point Dr, Suite 300, Wyomissing, PA 19610 Phone: 610-376-3738 Fax: 610-376-4780 | |
Dr. Winifred W Kao-seda, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Granite Point Dr, Suite 300, Wyomissing, PA 19610 Phone: 610-376-3738 Fax: 610-376-4780 |